Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20*
Open Access
- 20 February 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (8), 4914-4920
- https://doi.org/10.1074/jbc.m807169200
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Mechanistic Studies of a T20-Dependent Human Immunodeficiency Virus Type 1 VariantJournal of Virology, 2008
- Selection of T1249-Resistant Human Immunodeficiency Virus Type 1 VariantsJournal of Virology, 2008
- Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase InhibitorsJournal of Virology, 2008
- Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virusProceedings of the National Academy of Sciences of the United States of America, 2007
- Human Immunodeficiency Virus Type 1 Variants Resistant to First- and Second-Version Fusion Inhibitors and Cytopathic in Ex Vivo Human Lymphoid TissueJournal of Virology, 2007
- Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected PatientsJournal of Virology, 2006
- Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral IntegrationJournal of Virology, 2006
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Proline-induced disruption of a transmembrane α-helix in its natural environmentJournal of Molecular Biology, 1998
- Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migrationNature Medicine, 1998